New cancer clinical trial: Study of People With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System

Published on: May 28, 2018 at 12:00PM
Conditions:   Gastrointestinal Epithelial Cancer;   Gastrointestinal Neoplasm;   Cancer of Gastrointestinal Tract;   Cancer, Gastrointestinal
Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Aldesleukin;   Biological: CISH inactivated TIL
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2JiBAAo